Combining the 31-Gene Expression Profile Test for Cutaneous Melanoma With the American Joint Committee on Cancer Staging Identifies the Highest-Risk Patients With Stage I-II Disease. J of Skin 2023, 7 (4), s223. https://doi.org/10.25251/skin.7.supp.223.